Devyser Diagnostics AB publishes Interim Report for the period, January to June 2022
"Devyser reported another quarter of strong organic growth, which again saw record-breaking sales. The gross margin remained high. Both sales and margins have the potential for further improvement as we move forward with the transition from distributor sales to direct sales. Sales for the quarter amounted to SEK 31 million, equal to 42 percent organic growth compared with the same quarter of last year.” Fredrik Alpsten, CEO, Devyser Quarter April-June 2022 · Net sales amounted to SEK 30.9 million (21.8), corresponding to a 41.5% increase. Adjusted for exchange rate